BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 55.84 EUR Market Closed

Market Cap: €4.2B

P	PTC Therapeutics Inc XMUN:BH3	US
	Braster SA F:7UD	PL
O	Ortivus AB STO:ORTI B	SE
	Next Biometrics Group ASA LSE:0QWK	NO
	hhgregg Inc OTC:HGGG	US
	Flame Acquisition Corp NYSE:SOC	US
M	Mastercard Inc DUS:M4I	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

94%

Gross Margin is Increasing

94% > 97%

Exceptional Operating Margin

50%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-62% > 50%

Exceptional Net Margin

39%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-74% > 39%

Exceptional Free Cash Flow Margin

41%

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-42% > 41%

Negative ROE

-105%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

23%

ROIC is Increasing

-39% > 132%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.